- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04717102
Evaluating the Use of 0.5 and 0.75 MAC Desflurane in Patients Undergoing Spinal Surgery
Evaluating the Use of Desflurane in Patients Undergoing Spinal Surgery: A Randomized Controlled Trial Using 0.5 and 0.75 MAC Desflurane
Background: Somatosensory- (SSEPs) and motor-evoked potentials (MEPs) are commonly used as an intraoperative neurophysiologic monitoring tool to detect aberrations to the spinal cord integrity during spinal surgery. Inhalational anaesthetic agents have a significant influence on evoked potentials by suppressing the amplitude and prolonging the latency. Evidences suggest that total intravenous anaesthesia (TIVA) is superior to inhalation anaesthesia for neuromonitoring in spinal surgery, and support the use of up to 0.5 minimum alveolar concentration (MAC) of inhalational anaesthetic agents in these procedures.
Methods: Patients undergoing spinal surgeries will be prospectively recruited and be induced with TIVA at baseline of the evoked potentials. They will be randomized to receive balance anaesthesia with A) Desflurane MAC 0.5+remifentanil, or B) Desflurane MAC 0.75+remifentanil until the end of surgery. Influence of 1.0 MAC desflurane on the evoked potentials after the completion of surgery will also be studied.
Desired Results: Endpoints include the changes to the amplitude and latency of SSEPs and MEPs with 0.5 and 0.75 MAC desflurane. The findings will indicate the safety of desflurane at the studied concentrations for spinal surgeries, and substantial savings with the use of desflurane instead of TIVA.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Recording of Evoked Potentials characteristics:
The following characteristics of the evoked potential signals will be recorded:
- Amplitude: Size of the response, measured in microvolts (μV)
- Latency: Speed of the response, measured in milliseconds (ms)
- Morphology: Appearance of the response - Simple/Complex wave shape Baseline evoked potentials will be recorded at various points of surgery.
Anaesthesia variables:
At the time of recording of evoked potentials:
- Intraoperative temperature, blood pressure, ETCO2, anaesthesia depth - bispectral index monitoring (BIS), remifentanil TCI, MAC of desflurane, Train of Four, volume of propofol and remifentanil until randomization, total volume of desflurane and remifentanil used, anaesthetic medications used, FiO2, SpO2
Patient characteristics:
- Age, gender, race, weight, BMI, medications used, haematocrit, preop blood glucose (for Diabetics)
Safety considerations:
'Recommended standards for intraoperative monitoring of somatosensory evoked potentials', Guideline 11B of the American Clinical Neurophysiology Society (2009) and 'Intraoperative motor evoked potential monitoring - A position statement by the American Society of Neurophysiological Monitoring' will form the basis of the safety aspects of the study.
Conduct of Anaesthesia:
- The induction of anaesthesia will be achieved using targeted propofol and remifentanil infusions (TIVA). Muscle relaxants atracurium, rocuronium or suxamethonium will be used to facilitate intubation.
- Anaesthesia will be maintained on TIVA until the patient has recovered from muscle relaxant. Baseline characteristics (BC1) of the evoked potentials in TIVA will be obtained at this stage.
- Once the BC1 has been obtained, the patients will be randomized to two groups:
Group A- Anaesthesia maintained with 0.5 MAC desflurane/remifentanil infusion Group B- Anaesthesia maintained with 0.75MAC desflurane/remifentanil infusion
- Baseline characteristics 2 (BC2) will be obtained and the decision to proceed with 0.5 or 0.75 MAC desflurane made.
- On completion of the neuromonitoring phase of surgery, as defined by completion of instrumentation and start of closure, all patients in Group A and B will be maintained with 1.0 MAC desflurane with remifentanil infusion. Baseline characteristics 3 (BC3) will be recorded at this stage.
- The remifentanil infusion will be titrated at various stages of surgery to maintain a stable BIS and will also be based on haemodynamic variables.
All patients will get additional analgesics and antiemetics as deemed necessary. Post-operative recovery will follow the standard industry norms.
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Seok Hwee Koo, PhD
- Phone Number: +6568504929
- Email: seok_hwee_koo@cgh.com.sg
Study Locations
-
-
-
Singapore, Singapore, 529889
- Recruiting
- Changi General Hospital
-
Sub-Investigator:
- Rajkumar Chandran
-
Contact:
- Lay Hwa Yew
-
Sub-Investigator:
- Prit Anand Singh
-
Sub-Investigator:
- Shree Kumar Dinesh
-
Sub-Investigator:
- Seok Hwee Koo
-
Sub-Investigator:
- Wee Lim Loo
-
Sub-Investigator:
- Terry Teo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients aged ≥ 21 years old, scheduled for spinal surgery.
- Patients who require SSEP/MEP and with no neurological deficits.
- Patients of American Society of Anesthesiologist I-III physical status.
- Consenting patients.
- Elective procedures.
Exclusion Criteria:
- Patients with sensory or motor deficits preoperatively.
- Patients with significant cardiovascular and/or respiratory disease.
- Emergency procedures.
- Cord injury secondary to trauma.
- Non-consenting patients.
- Category A patients (Prisoners).
- Patients with previous stroke.
- Patients with Hep C, HIV.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 0.75 MAC desflurane
The effects of 0.75 MAC desflurane on the amplitude and latency of evoked potentials in spinal surgeries will be examined.
|
Following induction of anesthesia by propofol, the patients will be maintained on 0.75 MAC desflurane with remifentanil infusion during spinal surgery.
Other Names:
On completion of the neuromonitoring phase of surgery, the patients will be maintained on 1.0 MAC desflurane with remifentanil infusion.
Other Names:
|
Active Comparator: 0.5 MAC desflurane
The effects of 0.5 MAC desflurane on the amplitude and latency of evoked potentials in spinal surgeries will be examined.
|
On completion of the neuromonitoring phase of surgery, the patients will be maintained on 1.0 MAC desflurane with remifentanil infusion.
Other Names:
Following induction of anesthesia by propofol, the patients will be maintained on 0.5 MAC desflurane with remifentanil infusion during spinal surgery.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of 0.5 MAC desflurane on evoked potentials - Amplitude (microvolts)
Time Frame: During surgery
|
Amplitude of somatosensory- and motor- evoked potentials with use of 0.5 MAC desflurane
|
During surgery
|
Effect of 0.5 MAC desflurane on evoked potentials - Latency (milliseconds)
Time Frame: During surgery
|
Latency of somatosensory- and motor- evoked potentials with use of 0.5 MAC desflurane
|
During surgery
|
Effect of 0.5 MAC desflurane on evoked potentials - Morphology (appearance of the response)
Time Frame: During surgery
|
Morphology of somatosensory- and motor- evoked potentials with use of 0.5 MAC desflurane
|
During surgery
|
Effect of 0.75 MAC desflurane on evoked potentials - Amplitude (microvolts)
Time Frame: During surgery
|
Amplitude of somatosensory- and motor- evoked potentials with use of 0.75 MAC desflurane
|
During surgery
|
Effect of 0.75 MAC desflurane on evoked potentials - Latency (milliseconds)
Time Frame: During surgery
|
Latency of somatosensory- and motor- evoked potentials with use of 0.75 MAC desflurane
|
During surgery
|
Effect of 0.75 MAC desflurane on evoked potentials - Morphology (appearance of the response)
Time Frame: During surgery
|
Morphology of somatosensory- and motor- evoked potentials with use of 0.75 MAC desflurane
|
During surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of 1.0 MAC desflurane on evoked potentials - Amplitude (microvolts)
Time Frame: intraoperative
|
Amplitude of somatosensory- and motor- evoked potentials with use of 1.0 MAC desflurane
|
intraoperative
|
Effect of 1.0 MAC desflurane on evoked potentials - Latency (milliseconds)
Time Frame: intraoperative
|
Latency of somatosensory- and motor- evoked potentials with use of 1.0 MAC desflurane
|
intraoperative
|
Effect of 1.0 MAC desflurane on evoked potentials - Morphology (appearance of the response)
Time Frame: intraoperative
|
Morphology of somatosensory- and motor- evoked potentials with use of 1.0 MAC desflurane
|
intraoperative
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Wai May Leong, MMed, Changi General Hospital
Publications and helpful links
General Publications
- Hasan MS, Tan JK, Chan CYW, Kwan MK, Karim FSA, Goh KJ. Comparison between effect of desflurane/remifentanil and propofol/remifentanil anesthesia on somatosensory evoked potential monitoring during scoliosis surgery-A randomized controlled trial. J Orthop Surg (Hong Kong). 2018 May-Aug;26(3):2309499018789529. doi: 10.1177/2309499018789529.
- Sloan TB, Toleikis JR, Toleikis SC, Koht A. Intraoperative neurophysiological monitoring during spine surgery with total intravenous anesthesia or balanced anesthesia with 3% desflurane. J Clin Monit Comput. 2015 Feb;29(1):77-85. doi: 10.1007/s10877-014-9571-9. Epub 2014 Mar 19.
- Macdonald DB, Skinner S, Shils J, Yingling C; American Society of Neurophysiological Monitoring. Intraoperative motor evoked potential monitoring - a position statement by the American Society of Neurophysiological Monitoring. Clin Neurophysiol. 2013 Dec;124(12):2291-316. doi: 10.1016/j.clinph.2013.07.025. Epub 2013 Sep 18. Review.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Desflurane01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia
-
Samsun UniversityCompletedAnesthesia | Regional Anesthesia | Anesthesia ManagementTurkey
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | Anesthesia | Anesthesia; Adverse EffectGermany
-
Novocol Pharmaceutical of Canada, Inc.CompletedAnesthesia, Local | Dental Anesthesia | Anesthesia, ReversalUnited States
-
Aligarh Muslim UniversityCompletedAnesthesia | Anesthesia Intubation Complication | Anesthesia; Adverse EffectIndia
-
Universitas Sebelas MaretIndonesia Endowment Fund for EducationNot yet recruitingAnesthesia | Anesthesia; Reaction
-
University of PecsCompleted
-
Hormozgan University of Medical SciencesUnknownAnesthesia | Anesthesia; FunctionalIran, Islamic Republic of
-
University of ChicagoRecruitingAnesthesia | Patient Satisfaction | Anesthesia Risks | Anesthesia Consent | Consent RetentionUnited States
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMNot yet recruitingPrediction Models for Cardiovascular and Neurocognitive Disease Risk in the General Population (CME)Anesthesia, Local | AnesthesiaFrance
-
Matthew BorzageRecruitingAnesthesia | Anesthesia; ReactionUnited States
Clinical Trials on 0.75 MAC desflurane
-
Konkuk University Medical CenterUnknownValvular Heart DiseaseKorea, Republic of
-
Seoul National University HospitalCompletedStabilizing Hypnotic Depth and Vital Sign During Balanced AnesthesiaKorea, Republic of
-
Tianjin Medical University General HospitalCompletedNeuromuscular Monitoring
-
Tetec AGWinicker Norimed GmbH; Aesculap AGCompletedCartilage DiseasesGermany, Switzerland
-
Inonu UniversityCompletedMorbid Obesity | Difficult Intubation | VideolaryngoscopyTurkey
-
Alexandria UniversityActive, not recruitingEffectiveness of C-MAC Video-stylet Versus C-MAC D- Blade Video-laryngoscope for Tracheal IntubationDifficult Intubation | Difficult Mask VentilationEgypt
-
Yonsei UniversityCompleted
-
Medical University of WarsawCompleted
-
The University of Texas Health Science Center,...CompletedIntubation; DifficultUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedCarcinoma, Non-Small-Cell Lung | Lung NeoplasmsUnited States